Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors

被引:20
|
作者
Proska, J [1 ]
Tucek, S [1 ]
机构
[1] ACAD SCI CZECH REPUBL,INST PHYSIOL,CR-14220 PRAGUE,CZECH REPUBLIC
关键词
muscarinic receptor; heart; allosteric control; allosteric interaction; eburnamonine; vincamine; alcuronium; strychnine;
D O I
10.1016/0014-2999(96)00169-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It was discovered recently that alcuronium and strychnine (which is a precursor of alcuronium) allosterically increase the affinity of cardiac muscarinic receptors for the antagonist, N-methylscopolamine. We have now investigated the effects of l-eburnamonine and vincamine, which are both closely related to strychnine. In experiments on rat heart atria, l-eburnamonine was found to increase the binding of [H-3]N-methylscopolamine with Ehlert's cooperativity coefficient alpha = 0.35, which indicates that the strength of its allosteric action is close to that of alcuronium and strychnine (alpha = 0.31 and 0.44, respectively). However, the affinity of l-eburnamonine for the cardiac muscarinic receptors is lower than the affinities of alcuronium and strychnine (k(AR) = 22.6 mu M, 0.15 mu M, and 3.4 mu M, respectively). In spite of its extremely close similarity to l-eburnamonine, vincamine has a negative allosteric effect on the binding of [H-3]N-methylscopolamine (alpha = 4.1; K-AR = 22.8 mu M). It is likely that a systematic investigation of the allosteric effects of the analogues of strychnine will not only yield new allosteric effecters on muscarinic receptors, but also clarify the structural features responsible for the direction (positive or negative) of their allosteric effect.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [1] POSITIVE ALLOSTERIC ACTION OF ALCURONIUM ON SOLUBILIZED CARDIAC MUSCARINIC RECEPTORS
    MUSILKOVA, J
    TUCEK, S
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1995, 27 (4-5) : 337 - 343
  • [2] Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors
    Jakubik, J
    Bacakova, L
    ElFakahany, EE
    Tucek, S
    [J]. MOLECULAR PHARMACOLOGY, 1997, 52 (01) : 172 - 179
  • [3] Allosteric modulation of muscarinic acetylcholine receptors
    Tucek, S
    Dolezal, V
    Jakubík, J
    Krejcíi, A
    Lysíková, M
    [J]. 5TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2000, : 117 - 123
  • [4] Allosteric modulation of muscarinic acetylcholine receptors
    Gregory, Karen J.
    Sexton, Patrick M.
    Christopoulos, Arthur
    [J]. CURRENT NEUROPHARMACOLOGY, 2007, 5 (03) : 157 - 167
  • [5] Allosteric regulation of muscarinic acetylcholine receptors
    Tucek, S
    Jakubik, J
    ElFakahany, EE
    Bacakova, L
    [J]. JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S73 - S73
  • [6] Allosteric Modulation of Muscarinic Acetylcholine Receptors
    Jakubik, Jan
    El-Fakahany, Esam E.
    [J]. PHARMACEUTICALS, 2010, 3 (09): : 2838 - 2860
  • [7] Positive effects of allosteric modulators on the binding properties and the function of muscarinic acetylcholine receptors
    Tucek, S
    Jakubik, J
    Dolezal, V
    El-Fakahany, EE
    [J]. JOURNAL OF PHYSIOLOGY-PARIS, 1998, 92 (3-4) : 241 - 243
  • [8] Allosteric drugs acting at muscarinic acetylcholine receptors
    Waelbroeck, M
    [J]. NEUROCHEMICAL RESEARCH, 2003, 28 (3-4) : 419 - 422
  • [9] Allosteric binding sites on muscarinic acetylcholine receptors
    Wess, J
    [J]. MOLECULAR PHARMACOLOGY, 2005, 68 (06) : 1506 - 1509
  • [10] Allosteric Drugs Acting at Muscarinic Acetylcholine Receptors
    Magali Waelbroeck
    [J]. Neurochemical Research, 2003, 28 : 419 - 422